TUKYSA 150 mg/1
tucatinib · TABLET · SEAGEN INC.
No Recall History
Plain English
TUKYSA is a tablet containing tucatinib at 150 mg/1, taken oral. Manufactured by SEAGEN INC..
Key Facts
- Brand Name
- TUKYSA
- Generic Name
- tucatinib
- NDC Code (Product)
51144-002- Manufacturer
- SEAGEN INC.
- Strength
- 150 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA213411
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 04/17/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
diarrhoea1,697 reports
fatigue918 reports
nausea896 reports
vomiting507 reports
off label use469 reports
death445 reports
malignant neoplasm progression414 reports
palmar-plantar erythrodysaesthesia syndrome388 reports
product dose omission issue359 reports
asthenia353 reports
Frequently Asked Questions
What is TUKYSA used for?
TUKYSA contains tucatinib. It is a tablet taken oral. Consult your doctor for specific uses.
Is TUKYSA a controlled substance?
TUKYSA is not classified as a controlled substance by the DEA.
What is the generic name for TUKYSA?
The generic name for TUKYSA is tucatinib. There are no other listed brand versions of tucatinib.
What is the NDC code for TUKYSA 150 mg/1?
The NDC (National Drug Code) for TUKYSA 150 mg/1 is 51144-002, listed by SEAGEN INC..
Other TUKYSA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)